Share Market Today: Sensex ends above 41k for second consecutive session; Nifty logs record closing of 12,154
businesstoday.in | Updated Nov 28, 2019, 03:57 PM IST
Share Market Today: Equity indices closed at record-high levels on
Wednesday after BSE Sensex and NSE Nifty recorded fresh lifetime highs,
ahead of November derivatives expiry. BSE Sensex ended at a record high
of 41,130.17, rising 109 points higher and NSE Nifty at 12,154, rising
53 points against its previous close. Yes Bank, Bharti Infratel, UPL, ICICI Bank, SBI, JSW Steel were among
major gainers on the Indices, while Zee Entertainment, Tata Motors,
Hindustan Unilever, Vedanta and Britannia were trading as the worst
performers. On the sectoral front, all the indices barring auto closed in the green
today, with over 3% advance in PSU banking scrips and 1% rise in realty
stocks.








SBI Cards, the credit card subsidiary of State Bank of India, has filed draft red herring prospectus for its initial public offer (IPO) with market regulator SEBI. Where SBI holds 76% in SBI Cards and rest of the stake is held by Carlyle Group.
YES Bank share price was the top gainer in Thursday's early trade after the stock gained 3.5% to Rs 70.65 on the BSE. The stock of the private sector lender will be in focus a day ahead of its board meets to consider various options for raising funds. YES Bank share on Wednesday closed 7.65% higher at Rs 68.25 on Sensex and ended 8.31% higher at Rs 68.40 on Nifty. The stock was top gainer on both indices on Wednesday's trade.
Tata Communications share price jumped 8% to Rs 455.8 on BSE today after the company announced that it has signed an agreement with Kacific Broadband Satellites Group for providing global internet andstate-of-the-art cyber security services for Kacific’s Ka-band satellite network.
The shrae price of Cipla rose 2% in Thursday's early trade on BSE to Rs 476.35 as the pharma major announced that its wholly owned subsidiary Cipla (EU) Limited, has signed an agreement with CitiHealth Imports Limited to acquire the remaining 40% stake in Cipla Pharma Lanka.